Faster global financial news!
Hengrui Medicine: Subsidiary Receives Notice of Approval for Drug Clinical Trials
svmuu.com04/01/2026 19:48
Complaint Report
Complaint Report
According to an announcement by Hengrui Medicine, Fujian Shengdi Pharmaceutical Co., Ltd., a subsidiary of Jiangsu Hengrui Medicine Co., Ltd., recently received the "Notice of Approval for Clinical Trials" issued by the National Medical Products Administration for HRS9531 Injection and HRS-5817 Injection, and will commence clinical trials in the near future.
Source：富途快讯 · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
Previous: China Passenger Car Association: Tesla (TSLA.O) sold 97,171 locally manufactured vehicles in the Chinese market in December 2025.
|
Next: With earnings season for major Wall Street banks fast approaching, Citigroup warns that a pullback is coming for Morgan Stanley: Overcrowded long positions face high expectations
24H Trending
-
1
Hong Kong 'Lonely Heart' Scammed for $3.3M in Crypto Romance Investment Fraud; Malaysian Authorities Express Displeasure Over Blockchain Week After-Party's OnlyFans Scandal
-
2
SpaceX is tightening its supply chain to reduce Chinese influence, aiming to keep Chinese nationals and parts out.
-
3
Bitcoin Future Purchase Difficulty Analysis: Scarcity, Regulation, and Market Trends
-
4
Binance Founder CZ States Storing Coins on Exchanges is Statistically Safer Than Self-Custody
-
5
TRX Latest Price $0.33: Will TRON Coin Still Be Worth Holding in H2 2026?
-
6
In-depth Analysis of CROISSANT Coin: Multiple Homonymous Projects Coexist, Investment Value and Risk Assessment
-
7
FIDA Token Value Potential Analysis: Its Role and Future Prospects in the Solana Name Service Ecosystem
-
8
Bitcoin nears $64,000, up 2% over 24 hours, as traders look past fourth Coldcard sweep
-
9
What is TOTOFO Coin? AnimalFam (TOTOFO) Project Analysis and Trading Channels
-
10
Cardano (ADA) Financial Transparency and Audit Progress: Addressing Community Concerns
Markets Today
Recommended Reading
Hot Topics
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
- User Agreement
- Privacy Policy
- Contact Us
- Business Partnerships
- Disclaimer
- Content Statement
- About Us
- Sitemap
Coming Soon!
